Protection of intellectual property is a strategic priority for the shareholders, employees and partners of Bioavlee. On January 27, 2016, the Company filed a patent application concerning the developed technology of bacteria identification. In the area of IP management Bioavlee is working closely with the renowned London-based company Gill Jennings & Every LLP, which provides services to the most demanding customers in the biotech and pharmaceutical industries.
